Answers are grounded in this paper and cite their sources.
Background: Recently, anti-ganglioside complex (GSC) antibodies were discovered among the various subtypes of Guillain-Barré syndrome.GSC is the novel glycoepitopes formed by two individual ganglioside molecules.Case Report: We present a 36-year-old man with overlap Miller Fisher syndrome and acute bulbar palsy who had anti-GSC antibody that provided diagnostic robustness.Conclusion: Anti-GSC testing could be considered important in patients who show atypical manifestation with negative antibody reaction against each constituent ganglioside.
No takes yet. Share an insight, caveat, or question.
Huh et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: